Laureate Biopharmaceutical Services, Inc.
201 College Road East
Princeton
New Jersey
08540
United States
Tel: 609-919-3400
Fax: 609-520-3963
Website: http://www.laureatepharma.com/
Email: info@laureatepharma.com
About Laureate Biopharmaceutical Services, Inc.
Laureate Biopharma is a full-service biopharmaceutical contract development and manufacturing organization. Laureate’s scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company’s portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate has served a global client base from its Princeton, New Jersey facility since 1981.Biopharmaceutical-Production Monoclonal Antibody Manufacturing Clinical Trials Manufacturing
54 articles about Laureate Biopharmaceutical Services, Inc.
-
Gallus Biopharmaceuticals, LLC Strengthens Biologics CMO Business With Acquisition of Laureate Biopharmaceutical Services, Inc.
10/1/2013
-
New HAE Drug Candidate from Dyax Corp. Produced by Laureate Biopharmaceutical Services, Inc.
8/26/2013
-
New Stroke Drug from ZZ Biotech Produced by Laureate Biopharmaceutical Services, Inc.
8/13/2012
-
Laureate Biopharmaceutical Services, Inc. Names James D. Utterback to Board of Directors
4/3/2012
-
Laureate Biopharmaceutical Services, Inc. Appoints Lisa Cozza as Vice President, Business Development
3/27/2012
-
Laureate Biopharmaceutical Services, Inc. Appoints Les Mintzmyer, Vice President, Operations
2/15/2012
-
FDA Approves Electronic Common Technical Document (eCTD) for Laureate Biopharmaceutical Services, Inc.'s Regulatory Submissions
9/8/2011
-
Laureate Biopharmaceutical Services, Inc. to Produce Biosimilar Product for Leading Generics Company
7/25/2011
-
Laureate Biopharmaceutical Services, Inc.'s Electronic Submission Gateway Approved
6/24/2011
-
Laureate Biopharmaceutical Services, Inc. Release: Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1
6/3/2011
-
Patrys Limited Release: Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1
5/13/2011
-
Laureate Biopharmaceutical Services, Inc. Appoints Ann M. Daus, Ph.D. Vice President, Quality
3/16/2011
-
Laureate Pharma, Inc. Changes Name to Laureate Biopharmaceutical Services, Inc.
1/31/2011
-
Laureate Pharma, Inc. Appoints Kathleen P. Bloch as Chief Financial Officer
12/13/2010
-
Laureate Pharma, Inc. Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
11/11/2010
-
Laureate Pharma, Inc. Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
10/6/2010
-
Laureate Pharma, Inc. Appoints Steven R. Johnson as Vice President, Business Development
9/28/2010
-
Laureate Pharma, Inc. and Iconic Therapeutics, Inc. Announce Production of Clinical Material
1/7/2010
-
Laureate Pharma, Inc. Welcomes Three New Members to Business Development Team
11/2/2009
-
Laureate Pharma, Inc. Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
10/21/2009